Skip to main content

Table 2 Complications, isolate pathogens, procedures and outcomes of hospital admissions for heart transplantation among patients with and without type 2 diabetes (T2D) in Spain, 2002–2021

From: Temporal trends and outcomes of heart transplantation in Spain (2002–2021): propensity score matching analysis to compare patients with and without type 2 diabetes

Year

2002–2005

2006–2009

2010–2013

2014–2017

2018–2021

P trend

T2D

Complications of HT, n(%)

46(26.9)

39(21.55)

52(33.77)

48(30.77)

79(42.47)

< 0.001

Pneumonia, n (%)

5(2.92)

2(1.1)

3(1.95)

7(4.49)

10(5.38)

0.131

Staphylococcus bacteremia, n (%)

5(2.92)

4(2.21)

1(0.65)

9(5.77)

19(10.22)

< 0.001

Streptococcus bacteremia, n (%)

0(0)

0(0)

1(0.65)

2(1.28)

2(1.08)

0.390

Gram-negative bacteremia, n (%)

5(2.92)

8(4.42)

5(3.25)

21(13.46)

9(4.84)

< 0.001

Pseudomonas aeruginosa, n (%)

3(1.75)

4(2.21)

3(1.95)

7(4.49)

14(7.53)

0.015

Cytomegalovirus infection, n (%)

1(0.58)

4(2.21)

1(0.65)

6(3.85)

8(4.3)

0.065

Hemodialysis, n (%)

10(5.85)

8(4.42)

12(7.79)

19(12.18)

33(17.74)

< 0.001

ECMO, n (%)

0(0)

2(1.1)

8(5.19)

14(8.97)

33(17.74)

< 0.001

Tracheostomy, n (%)

4(2.34)

9(4.97)

7(4.55)

7(4.49)

11(5.91)

0.587

LOHS, median (IQR)

24(21)

22(22)

20(16)

28(27.5)

28(30)

< 0.001

IHM, n(%)

25(14.62)

23(12.71)

22(14.29)

13(8.33)

21(11.29)

0.419

NO DIABETES

Complications of HT, n(%)

237(31.31)

215(28.22)

218(35.1)

245(33.15)

316(45.01)

< 0.001

Pneumonia, n (%)

41(5.42)

40(5.25)

46(7.41)

52(7.04)

63(8.97)

0.028

Staphylococcus bacteremia, n (%)

46(6.08)

43(5.64)

49(7.89)

49(6.63)

61(8.69)

0.127

Streptococcus bacteremia, n (%)

5(0.66)

1(0.13)

3(0.48)

3(0.41)

3(0.43)

0.620

Gram-negative bacteremia, n (%)

26(3.43)

35(4.59)

63(10.14)

98(13.26)

78(11.11)

< 0.001

Pseudomonas aeruginosa, n (%)

13(1.72)

17(2.23)

30(4.83)

32(4.33)

39(5.56)

< 0.001

Cytomegalovirus infection, n (%)

16(2.11)

20(2.62)

26(4.19)

41(5.55)

53(7.55)

< 0.001

Hemodialysis, n (%)

67(8.85)

84(11.02)

97(15.62)

141(19.08)

158(22.51)

< 0.001

ECMO, n (%)

2(0.26)

18(2.36)

54(8.7)

126(17.05)

164(23.36)

< 0.001

Tracheostomy, n (%)

29(3.83)

55(7.22)

60(9.66)

76(10.28)

83(11.82)

< 0.001

LOHS, median (IQR)

26(26)

25.5(31)

28(35)

33(42)

33.5(44)

 

IHM, n(%)

130(17.17)

158(20.73)

124(19.97)

125(16.91)

108(15.38)

0.046

  1. HT heart transplantation. ECMO extracorporeal membrane oxygenation. LOHS length of hospital stay; IQR: Interquartile range; IHM: In-hospital mortality. According to Bonferroni adjustment p values can be considered significant if < 0.0018 (0.05/28)